Georgia Southern University

Digital Commons@Georgia Southern
Health Policy and Community Health Faculty
Publications

Health Policy and Community Health,
Department of

3-20-2022

Association between Serum Lycopene and Lung Cancer Mortality:
An 18-Year Follow-up Study of a National Cohort
Evans Afriyie-Gyawu
Georgia Southern University, Jiann-Ping Hsu College of Public Health,
evansafriyiegyawu@georgiasouthern.edu

Padmini Shankar
Georgia Southern University, pshankar@georgiasouthern.edu

Gulzar H. Shah
Georgia Southern University, Jiann-Ping Hsu College of Public Health, gshah@georgiasouthern.edu

Alicia A. Brown
Georgia Southern University, Jiann-Ping Hsu College of Public Health, ab03581@georgiasouthern.edu

Shannon Cearley
Georgia Southern University, smc2278@yahoo.com
Follow this and additional works at: https://digitalcommons.georgiasouthern.edu/hpmb-facpubs
See next page for additional authors
Part of the Community Health Commons, Community Health and Preventive Medicine Commons, and
the Health Policy Commons

Recommended Citation
Afriyie-Gyawu, Evans, Padmini Shankar, Gulzar H. Shah, Alicia A. Brown, Shannon Cearley, Akwasi
Ampofo-Yeboah, Nathaniel Abrams, Jian Zhang. 2022. "Association between Serum Lycopene and Lung
Cancer Mortality: An 18-Year Follow-up Study of a National Cohort." Special Journal of Public Health,
Nutrition, and Dietetics, 3 (1): 1-17. source: https://sjphealth.spparenet.org/lung-cancer/
https://digitalcommons.georgiasouthern.edu/hpmb-facpubs/222

This article is brought to you for free and open access by the Health Policy and Community Health, Department of
at Digital Commons@Georgia Southern. It has been accepted for inclusion in Health Policy and Community Health
Faculty Publications by an authorized administrator of Digital Commons@Georgia Southern. For more information,
please contact digitalcommons@georgiasouthern.edu.

Authors
Evans Afriyie-Gyawu, Padmini Shankar, Gulzar H. Shah, Alicia A. Brown, Shannon Cearley, Akwasi AmpofoYeboah, Nathaniel Abrams, and Jian Zhang

This article is available at Digital Commons@Georgia Southern: https://digitalcommons.georgiasouthern.edu/hpmbfacpubs/222

Afriyie et al, 2022

Serum Lycopene and Lung Cancer Mortality

Association between Serum Lycopene and
Lung Cancer Mortality: An 18-Year Follow-up
Study of a National Cohort
Evans Afriyie-Gyawu,1 Padmini Shankar,2 Gulzar H. Shah, 3 Alicia
Brown,3 Shannon Cearley,4 Akwasi Ampofo-Yeboah5 Nathaniel Abrams,1
Jian Zhang,1
*****************************************************************

Metadata
Highpoints
* Utilizing NHANES data, the study looked at the association between serum lycopene
levels and lung cancer mortality.
* The retrospective cohort study assessed the role of lycopene on chronic disease risk,
particularly lung cancer.
* The findings of the study suggest that high serum levels of lycopene may decrease the
risk for lung cancer and improve survival among patients who have lung cancer.
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for the red pigment in tomatoes and tomato products. While many studies have shown a link
between lycopene and protection against the initiation and/or progression of lung cancer, data on
its effect on lung cancer survivability is limited.
Objective: The primary objective of this study was to see if there was a link between lycopene
levels in the blood and lung cancer mortality. A secondary goal was to see if dietary factors
influence lycopene levels in the blood.
Materials and Methods: A retrospective cohort study of 14,358 adults who took part in
Phase II of the National Health and Nutrition Examination Survey III was carried out (19911994). This dataset served as the baseline for a 15-year (1991-2006) follow-up study, which was
correlated with the National Death Index database. The Cox Proportional Hazards Regression
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Background: Lycopene is a carotenoid found in some fruits and vegetables that is responsible
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Lycopene is a carotenoid found naturally in
some fruits (such as watermelon, papaya,
and pink guava) and vegetables (such as
tomatoes, sweet bell peppers, and asparagus)
(1). Lycopene is the red pigment in tomatoes
and tomato products, and it has been found
that increasing dietary intake and blood
concentration reduces the risk of prostate
cancer and cardiovascular disease (2).
Tomatoes are the most abundant source of
dietary lycopene, accounting for 85 percent
of total dietary lycopene, with nutritional
values ranging from 0.9 to 9.27mg/100g (3).
Lycopene levels are higher in concentrated
foods such as ketchup, tomato paste, and
tomato sauce than in unprocessed tomatoes
(4).
It is important to note that heating (while
cooking) causes cell wall breakdown,
converting the natural all-trans form of
lycopene to its cis-isomerized state and
increasing its bioavailability in the intestine
(5)

However, lycopene bioavailability from
dietary sources is low, and long-term
consumption of high levels of dietary
calcium (found in dairy products) and some
mineral water products can further reduce
lycopene absorption, partly due to its
hydrophobic nature (2).
Lycopene bioavailability is estimated to be
5% when consumed as tomato juice and
23% when consumed as pure lycopene
mixed in olive oil. Another reason is that
calcium binds to some food components,
which reduces bioavailability when eaten
with foods containing lycopene due to
"partial/total masking of its inhibitory effect
on lycopene micellarisation" (2).
In vitro studies have shown that "calcium
cations bind to the negatively charged
micelles and thus diminish their charge,"
influencing lycopene uptake by enterocytes.
Even when combined with 500 mg of
calcium (half of the RDA for men),
lycopene's bioavailability is reduced (2).
Another factor to consider is the half-life of
lycopene in the human body to determine
the frequency of consumption to maintain
consistent plasma levels (6).
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Model was used to calculate the HR for all-cause and cancer-related deaths for individuals with
high, moderate, and low serum lycopene levels.
Results: The unadjusted hazard ratio (HR) of deaths associated with low serum lycopene levels
(25 percent cutoff) was 1.67 (95 percent CI=1.24-2.23) and 1.00, respectively (ref). After
controlling for multiple risk factors such as age and gender, the HR for lung cancer fatalities was
1.45 (95% CI=1.08-1.96) for low serum levels (25 percent cutoff) with a reference value of 1.00.
For low vs. high serum lycopene levels, the adjusted HR for lung cancer death using 3-level
categorization (and adjusted for fruits and vegetables) was 1.67 (95 percent CI=1.03-2.71). In
addition, the adjusted HR for lung cancer death using 3-level categorization (and unadjusted for
fruits and vegetables) was 1.68 (95 percent CI=1.04-2.72) for low serum lycopene levels vs. high
serum lycopene levels.
Conclusions: The results suggest that high serum lycopene levels may reduce the risk of dying
from lung cancer. Furthermore, lycopene may not only reduce the risk of lung cancer
development but may also improve survival among lung cancer patients. More research is
needed to understand the physiological mechanisms underlying this association.
Keywords: Serum lycopene, Lung cancer, Mortality risk, Cohort study
******************************************************************
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Furthermore, smoking causes inflammation,
which suppresses the immune system,
allowing cancer cells to avoid detection,
progress, and damage the DNA. Inhalation
of dust, ozone, mineral fibers, air pollution,
and tobacco smoke have been shown to
cause inflammation within the epithelial
tissue of the lungs, which has been linked to
the onset of respiratory diseases such as lung
cancer (18). Lycopene, a well-known
antioxidant, has the highest potential
antioxidant effect of all carotenoids (13),
and its consumption has been linked to a
lower risk of lung cancer (9).
Lycopene and beta-carotene were found in
lung tissues in a post-mortem study. This
lends credence to the notion that carotenoids
are a component of the lung's defense
mechanism against cancer formation (19).
Even though "tomatoes and tomato products
containing lycopene have been associated
with a lower risk of malignancies,
particularly prostate cancer," "many dietarybased epidemiological studies have yielded
less supportive results" (5).
Furthermore, while randomized controlled
trials in prostate cancer studies found no
effect of lycopene, meta-analyses of limited
observational evidence found that only high
lycopene intake has potential effects (20).
Lycopene has been shown in laboratory
studies to inhibit cancer cell growth or
prevent carcinogenesis when chemically
induced (13). Although experimental
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Lycopene, Lung Cancer and Other
Cancers
According to a report on the potential
relationship between some cancers and
lycopene, lycopene may play a role in
reducing the progression of lung and
prostate cancers (7). Although little is
known about the mechanism, it may be
similar to its protective mechanism against
disease development (8).
Because of their antioxidant properties,
fruits and vegetables should be consumed
daily to reduce the risk of developing certain
cancers (5, 9). Antioxidants protect vital
molecules in the body from oxidation by
removing free radicals (10, 11, 12).
Lycopene is a powerful antioxidant, and
several studies indicate that it may reduce
the risk of developing certain cancers such
as lung, prostate, and breast cancer (13).
Several epidemiological studies have found
a link between a lower risk of lung cancer
and other cancers in populations that
consume tomato-rich diets high in lycopene
(14, 15). Even with these findings, the
precise role of lycopene in the prevention of
lung cancer cell growth remains unknown,
necessitating further controlled clinical trials
(13).
Some mechanisms that have been proposed
to explain how lycopene can suppress
carcinogenesis include the use of its
antioxidant properties, the induction of
cytoprotective 'phase II' enzymes, decreased
lipid peroxidation, and the inhibition of
cancer cell proliferation (13).
Behavioral and other risk factors have also
been linked to the development of lung
cancer and death from it. Cigarette smoking
is the leading cause of lung cancer,
accounting for approximately 80% to 90%
of lung cancer deaths in the United States
(16).

Tobacco use causes oxidative stress in lung
cells, and the presence of free radicals in
cigarette smoke causes oxidative stress,
disrupting the balance between oxidation
and reduction (17). Over 4,000 chemicals
are found in cigarette smoke, including
"nicotine, carbon monoxide, acrolein, and
oxidant compounds" (18).
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In a double-blind randomized controlled
trial, for example, high doses of lycopene
and other nutrients were shown to have no
significant biomarker levels of prostatespecific antigens (PSA) between the treated
and control groups.
In fact, at the end of the supplementation
period, re-biopsy revealed that the treated
group had a higher incidence of prostate
cancer (21). While numerous studies have
shown a link between lycopene and
protection against the initiation and/or
progression of lung cancer, there is limited
data and research on its effect on lung
cancer survivability (19).
Objective
Thus, this study aimed to determine the
relationship (or lack thereof) between serum
levels of lycopene and lung cancer
mortality. We also aimed at examining
whether dietary factors are associated with
serum levels of lycopene.

Materials and Methods
Sample Size and Characteristics
This study used data from the National
Health and Nutrition Examination Survey III
(NHANES III), which was conducted
between 1988 and 1994. The National
Health and Nutrition Examination Survey
(NHANES) is a major program of the
National Center for Health Statistics

(NCHS), which is part of the US Centers for
Disease Control and Prevention (CDC) and
is responsible for producing vital health
statistics for the United States.
Every year, the NHANES examines a
representative sample (from the US
population) of approximately 5,000 people
(23). NCHS used a two-phased multistage
probability
sampling
of
the
noninstitutionalized
United
States
population. Phase I lasted from October 18,
1988, to October 24, 1991, and Phase II
lasted from September 20, 1991, to October
15, 1994.
This study's dataset was linked to the
National Death Index (NDI) database, which
included American adults over the age of
seventeen who were followed up to
December 2006. The NCHS connects survey
participants' data with NDI mortality data,
allowing for a variety of outcome studies to
be conducted to investigate the relationship
of a wide range of health factors with
mortality (24).
To determine the vital status and causes of
death among the study participants, a total of
12 identifiers (including social security
number, gender, and date of birth) were used
to link NHANES III participants with the
NDI (25).
Only people aged 19 and up were eligible to
participate from this pool. They were not
included in the study population if there was
no data on their family income, drinking,
smoking, educational level, or vegetable
consumption.
Following the application of all inclusion
and exclusion criteria, a total of 14,358 final
participants (as shown in Table 1) were
evaluated for the study.
The NHANES protocol was reviewed and
approved by the National Center for Health
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evidence is promising, clinical evidence to
support the use of lycopene supplements for
cancer prevention is currently lacking (13,
21).
This may be due, in part, to evidence from
recent studies indicating that lycopene is
more effective in preventing certain cancers
when consumed in tomato form rather than
as a purified supplement (22).
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Statistics' Institutional Review Board (IRB).
Because only a public dataset was used, the

current study was exempt from ethics review
by
the
authors'
university's
IRB

.
Table 1 - Tabular representation delineating the application of inclusion and exclusion criteria
of the samples, NHANES III follow-up study (1988-2006)
Step for
Exclusion

Reason for exclusion

Sample Size
before Exclusion

Sample
Excluded

1

Adults (age=19+) in surveys

17,388

2

N w/valid eligible for follow

17,375

13

3

N w/valid micronutrient test results

17,375

0

4

N w/valid income

15,691

1,684

5

N w/valid education

15,198

493

6

N w/valid drinking variable

15,198

0

7

N w/valid smoking information

14,471

727

8

N w/valid Vegetable information

14,358

113

Note: After applying all the inclusion and exclusion criteria, a total of 14,358 final participants
were evaluated for this study.

and was classified as college graduate and
above, some college, high school, or below.
Marital status was classified as either
married or single. The race and ethnicity
category was reduced to four options:
African American, White American,
Mexican American, or Other.
Health Risk Factors
Smoking was defined as “heavy” if
respondents reported smoking ≥40 cigarettes
in the past 5 days, and as “moderate” if <40
but >0 cigarettes were smoked in the past 5
days. Self-reported health was measured as
excellent, good to very good, or poor.
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Socioeconomic Status (SES)
The poverty income ratio (PIR) was
calculated using the previous year's income
and family size to determine the family
income level. A PIR1 is defined by the
federal government as being below the
poverty line. Income was divided into four
categories for our study: high-income

[PIR=4+], middle-income [PIR=2-3.99],
low-income [PIR=1.00-1.99], and poor
[PIR1]. Educational attainment was defined
as the highest level of education completed

Page

This dataset .in Table 1, was acquired during
in-home interviews and subsequent visits by
the study participants to a mobile
examination center as part of the NHANES
III. Standardized questionnaires were used
to collect the demographics and healthrelated information used in the study.
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Analysis of Serum Lycopene
Trained technicians used a standardized
protocol to collect blood samples from study
participants while maintaining controlled
and consistent environmental conditions.
These specimens were examined in a mobile
examination center. Whole blood was
collected into serum separator tubes without
anticoagulant treatment and held at room
temperature for 30–60 minutes before
centrifugation. Serum was separated, frozen
at 20°C, and transported on dry ice to the
Centers for Disease Control and Prevention
(CDC) central laboratory for priority
analyses.
The remaining samples were then stored at 70oC for 8 months to 5 years pending
lycopene
and
other
micronutrient
concentration analyses during Phase II of the
NHANES III. Based on the detected serum
lycopene levels, a distribution curve was
created. Lycopene had a detection limit of
0.63 g/dl. Sex-specific cutoffs were derived
from lycopene levels in patients' sera to
divide the study participants into three
groups:
The distribution's upper quartile (i.e., high
group) included males with lycopene serum
levels of 33.51 g/dL and females with 29.67
g/dL. Males with 18.14 g/dL and females

with 16.47 g/dL were in the lower quartile
(i.e., low group hereafter). The middle
quartile (i.e., moderate group) of lycopene
levels was found between the upper and
lower quartiles for both male and female
participants. With regard to fatalities and
other clinical
data, all laboratory
measurements were performed blindly.
Fatality
Follow-up
and
Identification
of
Causes
of
Death
A total of twelve identifiers (including social
security number, gender, date of birth, and
other demographics) were used to connect
NHANES III participants to the National
Death Index to obtain vital status and cause
of death. Over 96% of the deceased
participants and nearly all of the living
participants were successfully tracked down
and classified. The person-year (PY)
contributions of each participant were
calculated as the time between the baseline
examination and the person's death or
December 31, 2006. (if alive).
The average length of follow-up was 10.46
years, with a maximum of 18.08 years. The
cause of death was determined using the
underlying cause listed on the death
certificate. To code the cause of death,
which in this study was lung cancer, the
International Classification of Diseases,
Injuries, and Causes of Death (ICD) (10th
Revision) was used. To standardize the
codes, the NCHS recoded all deaths that
occurred before 1999 that were coded using
the ICD-9 system with the comparable ICD10 code.
Statistical Analysis
Software for Survey Design Analysis
(SUDAAN) was used to analyze the data.
Statistical tests were determined to be
statistically significant at a p-value of 0.05.
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Classification of body size was determined
using BMI generated from the weight in
kilograms divided by the square of their
measured height in meters. Body size was
categorized as “underweight” (BMI<18.5),
“normal” (BMI of 18.5-24.9), “overweight”
(BMI of 25.0-29.9), and “obese” (BMI ≥
30). Vegetable and fruit/juice consumption
were measured as <1 per day, 1-2 per day,
or 3 or more per day. Cancer status was
established at baseline and was determined
to be a “positive” or “negative” diagnosis
from a physician at the time of the first
assessment.
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Hazard Ratios (HRs) were estimated using
the Cox Proportional Hazards Regression.
The Statistical Analysis System (Version
9.4) software was used to obtain unweighted
estimates.
The survival times were
estimated with the Kaplan–Meier method.
The estimates of the survival probability
function were obtained from Cox
proportional hazard regression models for
individuals with different lycopene levels.
The death rate (i.e., the number of deaths per
1000
person*years),
was
calculated
separately for the low, moderate, and high
lycopene groups. Cox Proportional Hazard
Regression models were used to estimate the
crude and adjusted HRs of dying from lung
cancer with varying concentrations of serum
lycopene levels. HRs were also adjusted for
age, sex, and other possible confounders like
vegetable consumption, race, level of
education, and family income.

Results
The majority (42.19%) of the participants
had moderate serum levels of lycopene
followed by low levels (38.88%) and then
high levels (18.93%). . Among individuals
who had low levels of serum lycopene at
baseline, about 48.91% had cancer, and
38.07% did not have cancer. This trend was
reversed among individuals with moderate
(37.35% - cancer and 42.58% - no cancer)
and high (13.74% - cancer and 19.35% - no
cancer) categories of serum lycopene levels
at baseline. The total deaths from all causes
of cancer among individuals aged 60+ in
this study were calculated to be 4.95%. Of
this amount, lung cancer mortality
accounted for 29.63%. These data suggest
an inverse association between serum
lycopene levels and lung cancer mortality.
Table 2 illustrates the association between
specific population characteristics and serum

levels of lycopene. African Americans
(20.84%) and White Americans (19.44%)
were significantly more likely to have high
serum levels of lycopene compared to
Mexican Americans (16.01%) and “Others”
(18.80%). Generally, those with lower
education, income, and self-reported health
levels had significantly lower serum levels
of lycopene.
There were significantly more individuals
who reported their health as “poor” (51%)
that had low serum levels of lycopene
compared to those who reported “good/very
good” (39.35%) or “excellent” (31.77%)
health. This trend reversed as the serum
lycopene levels increased from moderate to
high. The educational level of most of the
study participants was high school or less.
There was a significant relationship between
low levels of serum lycopene and low levels
of educational attainment. For instance,
participants whose highest level of
education was high school (42.47%) were
significantly more likely to have low serum
levels of lycopene compared to people who
completed some college (29.79%) or were
college graduates (34.05%).
There
were
noteworthy
bi-variate
associations between lycopene and deaths
due to cancer in adults older than sixty
years. As illustrated in Table 3, about
58.85% of all-cancer mortalities were found
in individuals who had low serum levels of
lycopene compared to those who had
moderate (29.92%) and high serum lycopene
levels (11.24%). With lung cancer
mortalities, there was also a significant
association with serum levels of lycopene.
Approximately 61.61% of lung cancer
mortalities were found in individuals who
had low serum levels of lycopene compared
to those who had moderate (27.49%) and
high serum lycopene levels (10.90%).
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Table 2 – Selected characteristics of the study population, by the level of Lycopene
14358 Adults, NHANES III follow-up study (1988-2006)1
Low level

Moderate level High level

N

%

N

%

N

Man

2,635

41.15

2,673

41.74

1,096 17.11

Woman

2,663

36.87

3,076

42.59

1,484 20.55

High-income (4+)

763

32.30

1,059

44.83

540

22.86

Mid-income (2-3.99)

1,546

34.84

1,949

43.92

943

21.25

Low-Income (1.00 -1.99)

1,647

43.42

1,506

39.70

640

16.87

Poor (PIR<1)

1,342

44.23

1,235

40.71

457

15.06

College graduate+

268

34.05

359

45.62

160

20.33

HS, some y of col

995

29.79

1,551

46.44

794

23.77

High School or below

4,035

42.47

3,839

40.41

1,626 17.12

An American

1,453

39.02

1,495

40.15

776

20.84

M Americans

1,343

39.23

1,532

44.76

548

16.01

Others

210

39.47

222

41.73

100

18.80

W American

2,292

38.53

2,500

42.03

1,156 19.44

Heavy

781

34.09

1,027

44.83

483

Light/Moderate

3,446

38.26

3,833

42.56

1,727 19.18

Rare/never

1,071

45.97

889

38.15

370

15.88

Heavy

892

41.90

841

39.50

396

18.60

Light/Moderate

653

39.15

721

43.23

294

17.63

Rare/never

3,753

38.18

4,187

42.59

1,890 19.23

Excellent

1,793

31.77

2,585

45.81

1,265 22.42

Good or very good

1,922

39.35

2,079

42.57

883

18.08

Poor

1,581

51.07

1,084

35.01

431

13.92

Cancer at baseline (+)

495

48.91

378

37.35

139

13.74

Cancer at baseline (-)

4,802

38.07

5,371

42.58

2,441 19.35

<1 /day

596

41.27

584

40.44

264

1-2/day

2,854

38.67

3,113

42.18

1,413 19.15

3 or +/day

1,848

38.48

2,052

42.72

903

18.80

<1 /day

1,733

37.01

2,024

43.23

925

19.76

1-2/day

2,712

39.59

2,871

41.91

1,267 18.50

3 or +/day

835

40.69

836

40.74

381

Family income level

Education attainment

Race and Ethnicity

Alcohol Drinking

Cigarette smoking

Self-reported health

Cancer status at baseline

Vegetable consumption

Fruit/juice consumption

21.08

18.28

P-Value2
0.0000
0.0000

0.0000

0.0000

0.0000

0.0124

0.0000

0.0000
0.3637

0.0199

18.57

Abbreviations: HS, high school; NHANES, The National Health Examination, and Nutrition Survey.
1The characteristics were measured at baseline conducted from 1988-1994; 2Statistics were generated from chi-square tests.
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Table 3 – The bi-variable association between various death causes and Lycopene among
14358 Adults aged 60+, NHANES III follow-up study (1988-2006) 1
Cause of Death1

Death (Died)

All Cancer

Yes

Lung Cancer

Yes

Serum level
H, M, L

No. of
Deaths

%

P-Value2

Low
Moderate

419
213

58.85
29.92

0.0000

High

80

11.24

Low
Moderate
High

130
58
23

61.61
27.49
10.90

0.0000

Abbreviations: HS, high school; NHANES, The National Health Examination, and Nutrition Survey.
Baseline survey was conducted from 1988-1994, and the cutoff of follow-up is December 31, 2006
Statistics were generated from chi-square tests.

1
2

Table 3: HRs were used as a form of additional analysis of the cancer mortality data. Unadjusted
and adjusted HRs analyzed the association of low serum levels (which is less than 25% of all the
serum lycopene concentrations) of lycopene with cancer-related deaths (of which lung cancer
was inclusive). This was then adjusted for age, sex, race, family income, educational attainment,
alcohol intake, and smoking behavior.
Table 4: The HR for low serum levels of lycopene and lung cancer mortality were found to be
Table 4 - Rates and hazards ratios of deaths from all and specific causes, by the level of Lycopene
in 14358 Adults aged 60+, NHANES III followup study (1988-2006)1,2
Causes
of death
All Cancer

Lung Cancer

Serum level

Sample N

Person*ye
ar

Death
rate

Death N

Hazard
Ratio 3

LL 95%CI

UL 95%CI

.

14,358

191,633

712

3.72

.

.

.

Low

5,298

65,310

419

6.42

1.28

0.99

1.65

Moderate

5,749

80,065

213

2.66

0.95

0.73

1.24

High

2,580

36,617

80

2.18

1.00

.

.

.

14,358

191,633

211

1.10

.

.

.

Low

5,298

65,310

130

1.99

1.67

1.03

2.71

Moderate

5,749

80,065

58

0.72

1.01

0.61

1.67

High

2,580

36,617

23

0.63

1.00

1
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Adjusted for age, sex, race, family income, education attainment, alcohol drinking, cigarette smoking, fruits, and
vegetable consumption assessed at baseline survey. Stroke at baseline was not included to avoid over-adjustment
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Abbreviations: NHANES, The National Health Examination, and Nutrition Survey; LL, lower limit; UL, upper limit; CI,
confidence interval.
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significantly associated, with an HR of 1.67 (1.03-2.71) and a death rate of 1.99 as illustrated in
Table 4. Results also show a link between an increased risk of lung cancer deaths and low serum
lycopene levels. There was also a significant association between low serum levels of lycopene
and both the unadjusted and adjusted HR (for age, sex, race, family income, education
attainment, alcohol drinking, cigarette smoking, fruits, and vegetable consumption).
Table 5 – Hazard ratios (adjusted and unadjusted) of cancer-related death, associated with a low level of
lycopene (25% as Cutoff) with 14,358 adults, NHANES III follow-up study (1988-2006)
Cause of Death

Unadjusted1 Hazard Ratio

Adjusted2 Hazard Ratio

All Cancer

1.39 (1.19-1.63)

1.27 (1.08-1.49)

Lung Cancer

1.67 (1.24-2.23)

1.45 (1.08-1.96)

Abbreviations: NHANES, The National Health Examination, and Nutrition Survey.
1Adjusted

for age and sex , 2Adjusted for age, sex, race, family income, education attainment, alcohol drinking,
cigarette smoking

Table 5 shows that after adjusting for age, sex, race, family income, education, alcohol drinking,
and cigarette smoking, study participants with low serum lycopene levels had 1.45 (1.08-1.96)
times increased risk of lung cancer mortality, and 1.27 (1.08-1.49) times greater risk for allcancer deaths compared to the high serum lycopene levels (ref=1). Unadjusted low serum
lycopene levels can also increase the risk for lung cancer mortality by 1.67 times (1.03-2.71).
Using a three-level serum concentration categorization (i.e., low vs. high and moderate vs. high),
low levels of lycopene were significantly associated with 1.67 (1.03-2.71) increased risk of lung
cancer mortality compared to individuals with high serum lycopene levels even after adjusting
for fruits and vegetables.
Table 6. HR (Adjusted and Unadjusted for fruits and vegetables) of death associated with a low level of
lycopene Using 3-Level Categorization with 14,358 adults, NHANES III follow-up study (1988-2006)

Lung Cancer

HR1 (Unadjusted for
Fruits and Vegetables)

HR1 (Adjusted for Fruits
and Vegetables)

Low vs High

1.30 (1.01-1.68)

1.28 (0.99-1.65)

Moderate vs High

0.96 (0.74-1.35)

0.95 (0.73-1.24)

Low vs High

1.68 (1.04-2.72)

1.67 (1.03-2.71)

Moderate vs High

1.02 (0.62-1.68)

1.01 (0.61-1.67)

Abbreviations: NHANES, The National Health Examination, and Nutrition Survey. 1Adjusted for age, sex, race, family
income, education attainment, alcohol drinking, cigarette smoking.
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Table 6 shows that the unadjusted HR for
fruits and vegetables was significant at 1.68
(1.04-2.72), thus indicating that there was a
68% higher risk of death from lung cancer in
people who had low serum levels of
lycopene when compared to study
participants with high serum lycopene
concentrations. Similar findings are
tabulated for the HR adjusted for fruits and
vegetables, with an HR of 1.67 (1.03-2.71).
Also, the unadjusted HR for fruits and
vegetables was significant at 1.30 (1.011.68), thus indicating that there was a 30%
higher risk of death from all-cancer in
people who had low serum levels of
lycopene compared to study participants
with high serum lycopene levels. While the
adjusted HR for fruits and vegetables
.

Serum Lycopene and Lung Cancer Mortality

appears to be 28% higher risk of death from
all-cancers (HR=1.28) among individuals
with high serum levels compared to low
levels, the associated risk is not statistically
significant (CI, 0.99-1.65).
The survival functions displayed in Figure 1
provide a visual representation of the
association between serum lycopene levels
and lung cancer survival. In the graphs, blue,
red, and green lines represent low, moderate,
and high serum levels of lycopene,
respectively.
Decreased
survivability
correlated with low serum levels of
lycopene. The most pronounced difference
was seen in those with low serum levels
having dramatically lower survivability
compared to moderate or high serum levels

Individuals with moderate levels of lycopene had the longest survivability in person-years (80,065 py)
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followed by low and high levels, with 65,310py and 36,617 py respectively.
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Figure 1. Survival Functions of the Serum Lycopene Levels, NHANES III Follow-up 1988-2006.
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Discussions
Because of its protective role in cancer
prevention and progression, the link between
serum lycopene levels and cancer mortality
warrants
further
investigation.
We
discovered that lower serum lycopene levels
increased the risk of death from lung cancer
in our analysis of the NHANES Survey
(1988-1994), which is a national
representation of the US population. This
study discovered a link between lung cancer
mortality and lycopene levels in the blood.
Lycopene is an antioxidant that can be found
in both natural and processed foods, such as
tomato peels (5, 9, 13). As previously stated,
several studies have been conducted to
investigate lycopene serum levels and their
role in cancer prevention and progression (7,
11, 13, 14, 15). According to the current
study, the majority of the study population
had moderate serum levels of lycopene, and
those with cancer were more likely to have
lower levels of lycopene than those without
cancer. Although some studies have found
no link between lycopene consumption and
the risk of certain cancers (26), our findings
are consistent with previous research that
found an inverse relationship between
lycopene levels in the blood and the
development of lung cancer. This could be
due to lycopene's role in preventing
oxidation, which can lead to gene mutation
and carcinogenesis (27).
Another finding from this study was that a
slightly higher percentage of heavy smokers
(41.90 percent) had low levels of lycopene
than those who never/rarely smoked (38.18).
Furthermore, a previous study found that
confounders such as smoking lower plasma
carotenoid (e.g., lycopene) levels in smokers
compared to non-smokers (28). This could

be due to several factors, including the fact
that smoking inhibits lycopene function and
is a major risk factor for the development of
lung cancer (29, 30). It is unclear whether
smoking status influences serum lycopene
levels in humans in this study. These
similarities support the association found in
our study between low serum lycopene
levels in smokers and lung cancer patients.
Our findings suggest that low lycopene
levels in the blood are linked to an increase
in lung cancer deaths. According to the
survival functions chart, patients with low
lycopene serum levels had lower
survivability than those with moderate or
high serum levels. This could be related to
the fact that lycopene slows the progression
of lung cancer in humans by inhibiting the
p53 gene, which is required for cancer
development (31). Thus, increasing dietary
lycopene
intake
or
lycopene
supplementation may play a role in lowering
lung cancer mortality.
One of the study's strengths is the possibility
of generalizability of our findings. Using the
NHANES as our data source ensures that the
study participants are representative of the
national population rather than just
individuals in clinical settings. As a result,
the contribution to the body of knowledge
surrounding lycopene could have a positive
impact on people's lives and enhance
sustainable development in the United States
and around the world. The NHANES sample
size is sufficient for a thorough analysis of
the data. Furthermore, to the best of our
knowledge, this is the first study to look at
the relationship between serum lycopene
levels and lung cancer mortality in the
American population. The majority of the
research found focused on serum lycopene
and cancer prevention. This study, on the
other hand, looked at lycopene levels in the
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Conclusion
This study provides evidence that there is a
link between lung cancer mortality and
lycopene levels in the blood. According to
the findings of the study, there is a
significant difference in lung cancer
mortality between individuals with low
serum lycopene levels and those with high
serum lycopene levels. As a result, it is
possible that lycopene could reduce the risk
of lung cancer development and possibly
improve the chances of survival in lung

cancer patients. Previous research suggests
that confounders such as smoking can lower
plasma carotenoid (e.g., lycopene) levels in
smokers
compared
to
nonsmokers.
Understandably, the relationship between
lung cancer mortality and low serum
lycopene levels is more complex and multidirectional than suggested. As a result, more
research is needed to investigate the
physiological mechanisms underlying the
link between lycopene and a reduction in
lung cancer mortality.
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